Showing results (151-160 of 199) with videos related to
Sort By:
Pageof 20
British Journal of Cancer|May 6, 2008
Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation studyA Awada, J Albanell, P A Canney, et al.Seminars in Oncology|October 1, 1996
An ongoing European organization for research and treatment of cancer crossover trial comparing single-agent paclitaxel and doxorubicin as first- and second-line treatment of advanced breast cancerM J Piccart-Gebhart, P Bruning, T Gamucci, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapyA Awada, L Dirix, L Manso Sanchez, et al.Saudi Medical Journal|September 5, 2001
Complications of carbon monoxide poisoningM S Al-Moamary, A S Al-Shammary, A A Al-Shimemeri, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1984
[Interatrial septal aneurysm. Echocardiographic diagnosis]M Canny, G Drobinski, D Thomas, et al.Investigational New Drugs|March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumorsE Raymond, J Alexandre, S Faivre, et al.ESMO Open|June 2, 2022
Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysisG Nader-Marta, D Martins-Branco, E Agostinetto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basisE Tomiak, M J Piccart, J Kerger, et al.European Journal of Cancer (Oxford, England : 1990)|January 24, 2006
Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?D Strumberg, A Awada, H Hirte, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1995
An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancerM J Piccart, P Bruning, J Wildiers, et al.Pageof 20